Toxic epidermal necrolysis induced by ritodrine in pregnancy: A case report.

World J Clin Cases

Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 201600, China.

Published: February 2022

Background: Preterm birth accounts for about 12% of all pregnancies worldwide and is the leading cause of neonatal morbidity and mortality. In order to avoid premature birth and prolong gestational age, tocolytics are the first and the best choice. Ritodrine is the most commonly used tocolytic medication. However, side effects such as pulmonary edema, hypokalemia, and hyperglycemia are known. Here we report a rare but serious side effect-toxic epidermal necrolysis (TEN)-caused by ritodrine.

Case Summary: A woman (31 years, gravida 4, para 2) was hospitalized because of premature contractions at 27 + 6 wk of gestation. A skin rash with pruritus appeared at 32 + 3 wk of gestation after administration of ritodrine, indomethacin, and dexamethasone, and it spread throughout the whole body in 3 d, particularly the four limbs. After 11 d' treatment, she was diagnosed with TEN. An emergency cesarean section was performed immediately to deliver the baby and intensive symptomatic treatment was promptly commenced after delivery. She recovered from the severe condition without any sequelae except for slight pigmentation after symptomatic treatment.

Conclusion: When a skin rash appears during the administration of ritodrine, we are supposed to consider the risk of TEN.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8855204PMC
http://dx.doi.org/10.12998/wjcc.v10.i4.1381DOI Listing

Publication Analysis

Top Keywords

epidermal necrolysis
8
skin rash
8
administration ritodrine
8
toxic epidermal
4
necrolysis induced
4
ritodrine
4
induced ritodrine
4
ritodrine pregnancy
4
pregnancy case
4
case report
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!